← All Sponsors
SPONSOR

Korea Institute of Oriental Medicine

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Non-small Cell Lung Cancer
NCT06249854 Phase 2
Recruiting

Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer
South Korea View Trial →